Company / Interest Expense
FATE THERAPEUTICS INC Interest Expense History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$1.8M
FY2021
5-year range
$1.8M / $1.8M
FY2017-FY2021
Trend
+3.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $1M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2021 with a 5-year CAGR of +26.1%.
Increased from $1M to $2M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +26.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +26.1%, indicating consistent growth.
- In FY2021, interest expense increased 3.3% year-over-year.
- Peak interest expense was recorded in FY2017.
- Lowest interest expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $1.8M | +3.3% |
| FY2020 | $1.7M | +33.8% |
| FY2019 | $1.3M | -22.5% |
| FY2018 | $1.6M | -26.3% |
| FY2017 | $2.2M | +304.4% |
| FY2016 | $549.0K | -31.0% |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026